NPS Intelligence (beta)

Disclosed NPS & retention by vertical

Verticals  /  Pharma, medtech & health distribution  /  COMPASS Pathways plc
52
Latest disclosed NPS
8 Apr 2024
2
NPS entries
1 with a number
2024–26
Years covered
2 entries in all

In their words

“Maintained a very strong 52% net promoter score (according to Qualtrics XM Institute, a score of between 10 to 30% is good and a score of 30% or more is excellent) •”
— COMPASS Pathways plc · SEC proxy statement · filed 8 Apr 2024
“Improved our net promoter score by 32 points. • Strengthened our board by recruiting and appointing two new independent board members.”
— COMPASS Pathways plc · SEC proxy statement · filed 15 Apr 2026

NPS disclosures (2)

Search the database →

15 Apr 2026
NPSProgram

…Improved our net promoter score by 32 points. • Strengthened our board by recruiting and appointing two new independent board members.

— COMPASS Pathways plc · SEC proxy statement · filed 15 Apr 2026
SEC proxy statement ↗
8 Apr 2024
NPS52

…Maintained a very strong 52% net promoter score (according to Qualtrics XM Institute, a score of between 10 to 30% is good and a score of 30% or more is excellent) •

— COMPASS Pathways plc · SEC proxy statement · filed 8 Apr 2024
SEC proxy statement ↗

Retention disclosures (0)

Open in the retention database →

No retention figures yet.

Lighthouse companies in Pharma, medtech & health distribution

The whole vertical →

About these figures

Every figure here was publicly disclosed by the named company: press releases, annual reports, SEC filings, earnings calls and news coverage. Companies tend to publish their NPS when it is good, so these numbers run higher than a true industry average: read them as what leading companies in this vertical say publicly, not as an industry benchmark.

NPS runs from −100 to +100. Retention figures are reported as the company defines them (net revenue retention, gross revenue retention, customer retention rate, churn). Every entry links to its source in the full database.